A molecular tweezer antagonizes seminal amyloids and HIV infection.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Castellano, Laura M
Stürzel, Christina M
Hammond, Rebecca M
von Einem, Jens
Holmes, Veronica M
MetadataShow full item record
AbstractSemen is the main vector for HIV transmission and contains amyloid fibrils that enhance viral infection. Available microbicides that target viral components have proven largely ineffective in preventing sexual virus transmission. In this study, we establish that CLR01, a 'molecular tweezer' specific for lysine and arginine residues, inhibits the formation of infectivity-enhancing seminal amyloids and remodels preformed fibrils. Moreover, CLR01 abrogates semen-mediated enhancement of viral infection by preventing the formation of virion-amyloid complexes and by directly disrupting the membrane integrity of HIV and other enveloped viruses. We establish that CLR01 acts by binding to the target lysine and arginine residues rather than by a non-specific, colloidal mechanism. CLR01 counteracts both host factors that may be important for HIV transmission and the pathogen itself. These combined anti-amyloid and antiviral activities make CLR01 a promising topical microbicide for blocking infection by HIV and other sexually transmitted viruses.
CitationA molecular tweezer antagonizes seminal amyloids and HIV infection. 2015, 4: Elife
AffiliationInstitute of Experimental Virology, Twincore, Centre for Experimental and Clinical Infection Research, Hannover, Germany.
The following license files are associated with this item:
- The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection.
- Authors: Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J
- Issue date: 2009 Jun 2
- Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
- Authors: Roan NR, Sowinski S, Münch J, Kirchhoff F, Greene WC
- Issue date: 2010 Jan 15
- Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
- Authors: Ren R, Yin S, Lai B, Ma L, Wen J, Zhang X, Lai F, Liu S, Li L
- Issue date: 2018 Jul 16
- Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.
- Authors: Zirafi O, Kim KA, Roan NR, Kluge SF, Müller JA, Jiang S, Mayer B, Greene WC, Kirchhoff F, Münch J
- Issue date: 2014 Nov 12
- Mechanism of Inhibition of Beta Amyloid Toxicity by Supramolecular Tweezers.
- Authors: Mittal S, Bravo-Rodriguez K, Sanchez-Garcia E
- Issue date: 2018 Apr 19